Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Matrix | 4 | 2017 | 28 | 2.190 |
Why?
|
| Bone and Bones | 6 | 2019 | 119 | 1.580 |
Why?
|
| Bone Density | 7 | 2019 | 134 | 1.400 |
Why?
|
| Osteolysis | 5 | 2019 | 149 | 1.330 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 12 | 1.280 |
Why?
|
| Glycoproteins | 3 | 2018 | 58 | 1.190 |
Why?
|
| Bone Remodeling | 3 | 2019 | 44 | 1.120 |
Why?
|
| Biomarkers | 5 | 2019 | 689 | 1.090 |
Why?
|
| Osteoporosis | 2 | 2018 | 80 | 1.070 |
Why?
|
| Parathyroid Hormone | 2 | 2015 | 23 | 1.040 |
Why?
|
| X-Ray Microtomography | 7 | 2018 | 72 | 0.870 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 59 | 0.820 |
Why?
|
| Animals | 18 | 2019 | 4552 | 0.810 |
Why?
|
| Lactation | 2 | 2018 | 62 | 0.780 |
Why?
|
| Familial Hypophosphatemic Rickets | 1 | 2019 | 2 | 0.740 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 8 | 0.680 |
Why?
|
| Weaning | 1 | 2018 | 5 | 0.680 |
Why?
|
| Minerals | 1 | 2018 | 6 | 0.680 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2016 | 2 | 0.580 |
Why?
|
| Mutation | 1 | 2016 | 383 | 0.500 |
Why?
|
| Antibodies | 1 | 2014 | 65 | 0.490 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2019 | 451 | 0.490 |
Why?
|
| Bone Regeneration | 4 | 2015 | 68 | 0.490 |
Why?
|
| Calcitonin | 1 | 2014 | 15 | 0.490 |
Why?
|
| Fracture Fixation | 1 | 2014 | 24 | 0.490 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 14 | 0.490 |
Why?
|
| Diphosphonates | 1 | 2014 | 17 | 0.490 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 12 | 0.480 |
Why?
|
| Titanium | 1 | 2014 | 209 | 0.450 |
Why?
|
| Rats | 9 | 2019 | 854 | 0.450 |
Why?
|
| Osteogenesis | 3 | 2018 | 96 | 0.450 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 284 | 0.430 |
Why?
|
| Male | 13 | 2019 | 15621 | 0.380 |
Why?
|
| Implants, Experimental | 2 | 2019 | 29 | 0.360 |
Why?
|
| Mice | 4 | 2019 | 1607 | 0.360 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2018 | 863 | 0.360 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 938 | 0.360 |
Why?
|
| Phosphates | 2 | 2019 | 20 | 0.350 |
Why?
|
| Femur | 4 | 2018 | 396 | 0.340 |
Why?
|
| Female | 7 | 2019 | 16197 | 0.300 |
Why?
|
| Polyethyleneimine | 3 | 2015 | 6 | 0.300 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 1942 | 0.300 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 11 | 0.280 |
Why?
|
| Skull | 2 | 2015 | 25 | 0.260 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 22 | 0.250 |
Why?
|
| Calcium | 2 | 2018 | 491 | 0.240 |
Why?
|
| Osteocytes | 2 | 2019 | 15 | 0.230 |
Why?
|
| Osteocalcin | 2 | 2019 | 19 | 0.220 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 166 | 0.220 |
Why?
|
| Plasmids | 3 | 2015 | 44 | 0.190 |
Why?
|
| Prosthesis Failure | 2 | 2014 | 556 | 0.190 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2019 | 2 | 0.190 |
Why?
|
| Fibroblast Growth Factors | 1 | 2019 | 7 | 0.180 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 521 | 0.180 |
Why?
|
| Body Weight | 1 | 2019 | 133 | 0.180 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2017 | 86 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 75 | 0.170 |
Why?
|
| Collagen | 2 | 2016 | 102 | 0.170 |
Why?
|
| Porosity | 1 | 2018 | 71 | 0.170 |
Why?
|
| Humans | 8 | 2019 | 29337 | 0.170 |
Why?
|
| Hyperostosis | 1 | 2018 | 1 | 0.170 |
Why?
|
| Syndactyly | 1 | 2018 | 2 | 0.170 |
Why?
|
| Anabolic Agents | 1 | 2018 | 6 | 0.170 |
Why?
|
| Osseointegration | 2 | 2019 | 76 | 0.160 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 102 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 30 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 142 | 0.160 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 724 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2018 | 503 | 0.150 |
Why?
|
| Pregnancy | 1 | 2018 | 403 | 0.150 |
Why?
|
| Cortical Bone | 1 | 2017 | 7 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 35 | 0.150 |
Why?
|
| Prevalence | 1 | 2018 | 487 | 0.150 |
Why?
|
| Comorbidity | 1 | 2018 | 498 | 0.150 |
Why?
|
| X-Rays | 1 | 2016 | 5 | 0.140 |
Why?
|
| Point Mutation | 1 | 2016 | 30 | 0.140 |
Why?
|
| Radiography | 1 | 2018 | 678 | 0.140 |
Why?
|
| Prognosis | 1 | 2018 | 840 | 0.140 |
Why?
|
| Independent Living | 1 | 2018 | 281 | 0.140 |
Why?
|
| RNA | 1 | 2015 | 39 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2018 | 679 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 248 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2016 | 298 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 46 | 0.130 |
Why?
|
| Phenotype | 1 | 2016 | 355 | 0.130 |
Why?
|
| Genotype | 1 | 2016 | 405 | 0.130 |
Why?
|
| Copper | 1 | 2014 | 9 | 0.130 |
Why?
|
| Chitosan | 1 | 2014 | 4 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2015 | 303 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 65 | 0.130 |
Why?
|
| Diaphyses | 1 | 2014 | 4 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 432 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 39 | 0.130 |
Why?
|
| Aged | 2 | 2018 | 9448 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 18 | 0.130 |
Why?
|
| Microvessels | 1 | 2014 | 16 | 0.130 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 26 | 0.130 |
Why?
|
| Fracture Healing | 1 | 2014 | 40 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2014 | 47 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 85 | 0.120 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2014 | 24 | 0.120 |
Why?
|
| Thiophenes | 1 | 2014 | 13 | 0.120 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 16 | 0.120 |
Why?
|
| Joints | 1 | 2014 | 97 | 0.120 |
Why?
|
| Models, Animal | 1 | 2014 | 126 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1113 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 90 | 0.120 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 4 | 0.120 |
Why?
|
| Joint Prosthesis | 1 | 2014 | 83 | 0.120 |
Why?
|
| Corpus Striatum | 1 | 2014 | 111 | 0.120 |
Why?
|
| Methamphetamine | 1 | 2014 | 48 | 0.120 |
Why?
|
| Humerus | 1 | 2014 | 98 | 0.120 |
Why?
|
| Bone Resorption | 1 | 2014 | 104 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 364 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2014 | 73 | 0.110 |
Why?
|
| Arthroplasty, Replacement | 1 | 2014 | 147 | 0.110 |
Why?
|
| Tibia | 1 | 2014 | 259 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 788 | 0.100 |
Why?
|
| Rats, Inbred F344 | 3 | 2015 | 48 | 0.100 |
Why?
|
| DNA | 3 | 2015 | 125 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 4851 | 0.080 |
Why?
|
| Calcification, Physiologic | 2 | 2019 | 20 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 487 | 0.080 |
Why?
|
| Biomechanical Phenomena | 2 | 2019 | 668 | 0.070 |
Why?
|
| Middle Aged | 1 | 2018 | 9823 | 0.060 |
Why?
|
| Cell Survival | 2 | 2015 | 169 | 0.060 |
Why?
|
| Genetic Therapy | 2 | 2015 | 89 | 0.060 |
Why?
|
| Surface Properties | 1 | 2019 | 144 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 127 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 116 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 2 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 58 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 27 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3478 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 102 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2018 | 174 | 0.040 |
Why?
|
| Spine | 1 | 2018 | 121 | 0.040 |
Why?
|
| Motor Activity | 1 | 2019 | 369 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 2015 | 11 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 57 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 35 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 263 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 5 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 9 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 16 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2014 | 24 | 0.030 |
Why?
|
| Self Administration | 1 | 2014 | 36 | 0.030 |
Why?
|
| Corrosion | 1 | 2014 | 139 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 166 | 0.030 |
Why?
|
| Hypoxia | 1 | 2014 | 60 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 101 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 125 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 60 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 116 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 394 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2013 | 201 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 226 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2014 | 502 | 0.030 |
Why?
|
| Risk Factors | 1 | 2014 | 2443 | 0.020 |
Why?
|